Protalix BioTherapeutics Announces $20 Million Milestone Payment from Chiesi Global Rare Diseases ...Middle East

Milestone payment triggered by FDA approval of ELFABRIO® (pegunigalsidase alfa-iwxj) and payable within 30 days of approval CARMIEL, Israel, May 18, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production...

Hence then, the article about protalix biotherapeutics announces 20 million milestone payment from chiesi global rare diseases was published today ( Thursday 18/05/2023 - 01:52 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Protalix BioTherapeutics Announces $20 Million Milestone Payment from Chiesi Global Rare Diseases )

Also on site :

• Israeli footballer’s role in assault on southern Lebanon sparks outrage
• ‘We can insure the ship, but we cannot insure a human life.’
• How the US memeifies its war on Iran